Subcutaneous Skyrizi beneficial in delayed, non-responders to IV induction therapy for CD

Press/Media

Period	2 Nov 2022

Media coverage

Title	Subcutaneous Skyrizi beneficial in delayed, non-responders to IV induction therapy for CD
Media name/outlet	Healio
Country/Territory	United States
Date	2/11/22
URL	ct.moreover.com/?a=49148236087&p=1gw&v=1&x=p-K-ppZUV80lKD1JlRRsyg
Persons	Marla Dubinsky